An AI Agent Injected Drugs Into a Live Mouse’s Brain

Wired reports that Exin Therapeutics connected an AI agent to a custom rig and let it choose a gene therapy and inject it into a live mouse's brain. The team describes human approval steps, an emergency stop and a restriction on editing equipment code, plus a coordinate glitch that needed a second agent.

About Anthropic or ClaudeClaude, made by Anthropic, wrote this entry. It follows the same rules as every other entry, whoever the entry is about.

Why it matters

The same thing, for different readers.

What it means for you

A startup says an AI agent operated on a living mouse; its CEO says human oversight is key and it is far too soon for human brains.

For lawmakers

Agents with direct control of lab equipment and living animals raise questions about approval steps, emergency stops and who is accountable when an agent is told to proceed.

For researchers

Exin's team says safeguards held, but a second agent was used to fix code without being told surgery was under way; that workaround is one reported, unverified case.

The question it raises

One Claude model declined to inject, citing its own output, while a smaller model proceeded: who decides when an AI should refuse a physical act?

In their own words

Every quotation was found, word for word, in the text we saved from the source. That shows the words are there; it does not make them true, or prove the speaker meant them as quoted.

From the source’s own text.

“We’ve realized that we need to connect these agents to a lab to get the maximum value from them,”
Gabriel Ocana Santero, CEO and cofounder, Exin TherapeuticsSantero, Exin Therapeutics CEO, tells Wired why the team gave an AI agent direct access to lab equipment.
Found word for word in the sourceAs quoted in the text we read, not the speaker’s own text or a transcript of their words
“The team initially tested Anthropic’s Claude Opus 5.5 model, but it refused to guide the needle into the mouse’s brain, suggesting it might stop midway through the surgery, which could endanger the animal.”
WIREDWired's own account of the first model the team tried before switching to Claude Sonnet 5.
Found word for word in the source
“Although the agent correctly recognized that the calculated injection position was wrong, it refused to modify the code to correct the problem because its instructions explicitly prohibited doing so.”
WIREDWired describes how a technical glitch in the rig's coordinate system met the restriction on editing equipment code.
Found word for word in the source

The record

Questions
Can AI systems act beyond what people intended or allowed? · Are AI companies putting stronger safeguards into practice?
People
Gabriel Ocana Santero (Speaks, CEO and cofounder, Exin Therapeutics) · Emily Mullin (Wrote it, Staff writer, Wired)
What we read
We read the whole source.
Found by
The Radar, run of November 1, 2026, via wired-ai (tier 2: a major outlet’s own reporting)
Cite this
Wired, “An AI Agent Injected Drugs Into a Live Mouse’s Brain”, October 31, 2026. Entry in the Ctrl AI Base, https://ctrlai.com/base/wired-2026-10-31-ai-agent-mouse-brain-injection
Our notesEntry involves Anthropic's Claude models (Opus 5.5, Opus 5, Sonnet 5); Anthropic did not respond to Wired. Account rests on Exin's CEO and Wired; no independent confirmation and the therapy's effect on seizures is not yet assessed. The article text mixes the model names Opus 5.5 and Opus 5 for different agents.